Data from the Baby Siblings Research Consortium confirm and specify the nature of the female protective effect in autism: A commentary on Messinger et al.
Sibling recurrence data from the Baby Siblings Research Consortium (BSRC) recapitulate results from very large clinical family studies that demonstrate the absence of the Carter effect and provide clarification of the nature of the female protective effect in ASD. This legacy prospective data collection confirmed marked differences in the proportions of males versus females who lie along deviant trajectories of social development in the setting of inherited liability to autism—a phenomenon which defines the female protective effect—and demonstrate that among affected children, sex differences are modest and homologous to those observed among non-ASD children.
Background
I read with great interest the report and analysis of the extensive collection of data by the Baby Siblings Research Consortium regarding early sex differences [1]. Given the rarity of such a large, prospective data collection (1241 infant siblings from 15 sites), these results will and should command considerable attention in the scientific community. It was, however, potentially misleading for the authors to conclude that the data did not support a “female protective effect” hypothesis, and this presents an opportunity to clarify the implications of the results as well as what is meant by the term “female protective effect.”
What the data suggested, replicating what has actually been previously reported by numerous prior studies [2, 3], is the absence of the so-called “Carter effect.” The Carter effect is the observation of the expectation that if a higher quantitative burden of genetic susceptibility is required to cross the threshold of affectation in one sex versus another, then one should observe a higher level of familial aggregation of the disorder among the relatives of probands of the sex that has the higher threshold. As is true for large registries in the USA and Europe [4‐6], the Carter effect was not observed for ASD in the Baby Siblings Research Consortium (BSRC) sample. But the absence of the Carter effect is not the same as the absence of a female protective effect.
Anzeige
Main Text
The manuscript describes the BSRC observation that across a number of developmental competencies, modest sex differences were observed, and the discrepancy between boys and girls with ASD was not different in magnitude from that between typically developing boys and girls. The authors conclude that therefore sex differences were “not autism-specific.” Examining males and females within the category of the disease-of-interest is an important exercise in understanding sex differences, but there can be profound ASD-specific sex effects on a disease that render sex differences among affected subjects relatively minor and indistinguishable from those differentiating typical boys and girls. Conduct disorder provides an excellent example—the differences between males and females who meet diagnostic criteria are minimal (by definition) and yet males are six times more likely to be affected than females.
In the case of ASD, the first major clue generated by these data was that the magnitude of sex difference for any given trait within any subject group was dwarfed by the magnitude of difference across groups (ASD versus non-ASD). Since the “quantum leap” from typicality to clinical abnormality (the magnitude of which, in relation to within-group differences, is illustrated in figure) occurred over three times more commonly for male siblings than for female siblings (this was the second major clue generated by the study data), the data actually represent a remarkable manifestation of sex-specific modulation of inherited liability, which is the fundamental nature of the so-called female protective effect. The refocusing of the problem on contrasts across groups rather than within groups is represented by comparing the arrows and relative sample sizes in Fig. 1, which is a schematic reconstruction-to-scale of Figure three of the original manuscript.
Fig. 1
Schematic reconstruction of Figure 3 (panel A) of the original manuscript (Messinger et al. 2015). ADOS social affect scores of high-risk infant siblings (n = 1241, 58 % male), males in black, females in red; for children deemed “non-ASD”, dashed lines; children deemed “ASD”, solid lines. The panel is schematically redrawn to scale, with line widths depicting respective sample proportions. Whereas 193 males deviated enough from normality (black arrow) to contribute to the categorically diagnosed group, only 59 females deviated enough from normality (red arrow) to contribute to the categorically diagnosed group. The female protective effect is best represented by this proportional contrast (represented by the relative width of the arrows depicting the proportion for each sex who crossed over from typicality to abnormality) rather than by sex differences within each group
×
In prior published work, we have presented evidence for the manner in which a female protective effect might operate in the absence of the Carter effect, essentially via a categorical mechanism of protection by which most females are protected from most forms of ASD [4, 7‐9]. The BSRC data reported in the manuscript is entirely consistent with such modulation of risk by sex, and we have shown in quantitative trait analyses among school-aged children in both the AGRE and IAN registries how such protection manifests itself among females in multiplex autism families [4, 10].
Conclusions
The BSRC data recapitulate results from very large clinical family studies that demonstrate the absence of the Carter effect and provide clarification of the nature of the female protective effect in ASD. The prospective data collection confirmed marked differences in the proportions of males versus females who lie along deviant trajectories of social development in the setting of inherited (autosomal) liability to autism—a phenomenon which defines the female protective effect—and demonstrate that among affected children, sex differences are modest and homologous to those observed among non-ASD children.
Anzeige
Acknowledgements
Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under Award Number U54 HD087011 to the Intellectual and Developmental Disabilities Research Center at Washington University.
Funding
U54 HD087011.
Availability of data and materials
Not applicable.
Authors’ contributions
Not applicable.
Authors’ information
John N Constantino MD is the Director of the William Greenleaf Elliot Division of Child Psychiatry at Washington University in St. Louis School of Medicine and the Psychiatrist-in-Chief at St. Louis Children’s Hospital. He is Co-Director of the Intellectual and Developmental Disability Research Center at Washington University. He is currently a Co-Principal Investigator for an NICHD-funded study entitled, "Sex-Specific Modulation of ASD Liability: Compensatory Mechanisms and Recurrence."
Competing interests
The author declares that he has no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Anzeige
Declarations
Not applicable.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Data from the Baby Siblings Research Consortium confirm and specify the nature of the female protective effect in autism: A commentary on Messinger et al.
Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.
Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.
